TBD Pharmatech’s recent addition of Preparative Flash Chromatography with an ELSD marks a significant enhancement in our “Small-molecule Novel Drug Ingredients Lab” project. This sophisticated…
Read moreTBD Pharmatech’s recent procurement of 150L Jacketed glass reactor with thermostat, as part of the “Small-molecule Novel Drug Ingredients Lab” project, will add new capabilities to our organic…
Read moreTBD Pharmatech laid the cornerstone for a new development and production building, which is part TBD Pharmatech’s development path and a contribution to Estonia’s knowledge-intensive entrepreneurship….
Read moreTBD Pharmatech’s CEO, Dr. Andrus Tasa, will be attending the prestigious 17th Annual European Life Science CEO Forum in person on February 28-29 in Zurich, Switzerland! This forum is a prime opportunity…
Read moreDuring the scientific competition organized by Rakett69 Teadusstuudio, and the teams of Wolf Group, Akzo Nobel, TBD Pharmatech, and Eesti Energia, prominent players in the Estonian chemical industry,…
Read moreTBD Pharmatech’s recent procurement of a large-scale flash chromatograph system, as part of the “Small-molecule Novel Drug Ingredients Lab” project (RE.5.04.23-0268, 01.09.2023 and…
Read more
API CDMO that delivers a tailored range of fine chemical development and manufacturing solutions to pharmaceutical and biotech companies.
